Clinical Trials · NCT07254572
Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- National Institute of Cardiology, Warsaw, Poland
- Enrollment
- 300
- Start date
- Jul 2025
- Locations
- 1 site, Poland
- Primary endpoint
- Evaluation of the effect of GLP-1 analogue treatment on coronary artery disease progression AND Evaluation of the effect of flozin treatment on the progression of coronary artery disease (CO-PRIMARY ENDPOINTS)